explore -WSS

explore

author：knowledge 2025-10-02 11:09:20 - browse：984

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Chemotherapy before breast cancer surgery might fuel metastasis

knowledge

leisure time

WSS

How a small hospital in rural Puerto Rico survived Hurricane Maria

Protect nursing home residents from future pandemics

How a small hospital in rural Puerto Rico survived Hurricane Maria

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Class action alleges UnitedHealth concealed DOJ probe

Welsh Carson private equity firm escapes from FTC antitrust case

hotspot

explore

hotspot

Bright Health sells Medicare Advantage business to Molina

PBM executives asked to testify by House panel

Medicare proposal to cover medical devices draws a mixed reaction

AI for drug discovery: Experts on separating hype from reality

Heart attack and stroke risk calculators need revising

PBM executives asked to testify by House panel

FDA approval of Sarepta Duchenne genetic therapy gives me hope

As health system earnings go up, health insurance stocks go down

Bright Health sells Medicare Advantage business to Molina

Should insurance cover cosmetic surgery?

hotspot

The Bio Revolution is changing business and society

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Guardant Health colon cancer test endorsed by FDA advisory panel

Is it ever OK for doctors to lie to their patients?

The effects of a landmark ruling on DNA ownership are becoming clearer

Deliver public health messages at the right time

knowledge

leisure time

explore

knowledge